Latest IEC article published on JAK inhibitors.   

The IEC is pleased to announce that the British Journal of Dermatology published the Council’s most recent manuscript, A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council, on September 10. With 31 authors, this open-access article draws on the global expertise of the Council to create a consensus opinion on a pragmatic approach to prescribing janus kinase inhibitors (JAKinibs), including appropriate patients, dosing, clinical and lab monitoring, and long-term use. JAKinibs hold great potential for treatment of moderate to severe atopic dermatitis but must be fully understood before prescribing.

For all IEC publications, see our expanded list.